<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
73362-202-01
</NDCCode>
<PackageDescription>
4 BOX in 1 CARTON (73362-202-01) / 1 KIT in 1 BOX (73362-202-02) * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (73362-206-01) * 1 SOLUTION in 1 SYRINGE, GLASS (73362-801-01)
</PackageDescription>
<NDC11Code>
73362-0202-01
</NDC11Code>
<ProductNDC>
73362-202
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Yuviwel
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Navepegritide
</NonProprietaryName>
<DosageFormName>
KIT
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20260227
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
NDA
</MarketingCategoryName>
<ApplicationNumber>
NDA219164
</ApplicationNumber>
<LabelerName>
Ascendis Pharma Endocrinology, Inc.
</LabelerName>
<SubstanceName/>
<StrengthNumber/>
<StrengthUnit/>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2026-03-27
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20260227
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>